5 unknown, 4 completed, 1 not yet recruiting, 1 terminated. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Unknown 5, Completed 4, Not yet recruiting 1, Terminated 1 |
Follow Coronary Atherosclerosis: new trials by email Literature Review of Coronary Atherosclerosis trials Research Report on Coronary Atherosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT icosapent ethyl (IPE), Standard LDL-C-Lowering Therapy - Coronary Artery Disease, Hyperlipidaemia | Phase 4 | Not yet recruiting | China National Center for Cardiovascular Diseases | 100 | 2026-08-01 | 2026-08-13 |
| A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis aspirin 100 mg/d, indobufen 200 mg bid - Coronary Atherosclerosis | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 60 | 2021-10-15 | 2022-01-19 |
| Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring continuous glucose monitoring (CGM) - Coronary Atherosclerosis | Phase 4 | Unknown | National Cerebral and Cardiovascular Center, Japan | 90 | 2019-03-01 | 2020-09-22 |
| the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy aspirin 100mg/d therapy, aspirin 100mg/2d therapy, aspirin 100mg/3d therapy - Coronary Atherosclerosis | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 210 | 2017-08-20 | 2017-07-31 |
| Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) Olmesartan medoxomil tablets, Antihypertensive medication (per doctor suggestion) - Coronary Atherosclerosis | Phase 4 | Unknown | Chinese PLA General Hospital | 100 | 2014-12-01 | 2015-02-11 |
| Routine Versus Selective Use of FFR to Guide PCI Fractional Flow Reserve (FFR) - Acute Coronary Syndrome, Coronary Atherosclerosis | Phase 4 | Terminated | Cardiology Research UBC | 261 | 2014-01-01 | 2019-02-26 |
| Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis Adalimumab, Placebo - Psoriasis, Vascular Inflammation | Phase 4 | Completed | Innovaderm Research Inc. | 107 | 2012-11-01 | 2016-09-09 |
| Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis iobitridol, gadoterate meglumine - Type 2 Diabetes Mellitus, Coronary Atherosclerosis | Phase 4 | Completed | Guerbet | 351 | 2010-08-01 | 2019-05-31 |
| Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis adalimumab, UVB Phototherapy, Topical treatment - Psoriasis, Vascular Inflammation | Phase 4 | Completed | Innovaderm Research Inc. | 30 | 2009-07-01 | 2011-10-28 |
| Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J) Calcium channel blockers (amlodipine, azelnidipine) - Hypertension, Coronary Atherosclerosis | Phase 4 | Completed | Juntendo University | 199 | 2005-12-01 | 2021-05-14 |
| Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients pioglitazone - Coronary Atherosclerosis, Inflammation | Phase 4 | Unknown | National Taiwan University Hospital | 120 | 2004-11-01 | 2006-02-27 |
Coronary Artery Disease (11) · Diabetes Mellitus, Type 2 (2) · Plaque, Amyloid (2) · Psoriasis (2) · Acute Coronary Syndrome (1) · Angina, Unstable (1) · Atherosclerosis (1) · Calcinosis (1) · Coronary Disease (1) · Hyperlipidemias (1) · Hypertension (1) · Hypertriglyceridemia (1) · Inflammation (1) · Insulin Resistance (1)
Arterial Occlusive Diseases (11) · Arteriosclerosis (11) · Cardiovascular Diseases (11) · Heart Diseases (11) · Myocardial Ischemia (11) · Vascular Diseases (11) · Coronary Disease (10) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Glucose Metabolism Disorders (3) · Pathological Conditions, Signs and Symptoms (3) · Diabetes Mellitus (2) · Endocrine System Diseases (2) · Pathological Conditions, Anatomical (2) · Skin Diseases (2)
Adalimumab (2) · Aspirin (2) · Therapeutics (2) · indobufen (2) · Amlodipine (1) · BID protein, human (1) · Calcium Channel Blockers (1) · Continuous Glucose Monitoring (1) · Olmesartan Medoxomil (1) · Pioglitazone (1) · azelnidipine (1) · eicosapentaenoic acid ethyl ester (1) · gadoterate meglumine (1) · iobitridol (1)
Innovaderm Research Inc. (2) · The First Affiliated Hospital with Nanjing Medical University (2) · Cardiology Research UBC (1) · China National Center for Cardiovascular Diseases (1) · Chinese PLA General Hospital (1) · Guerbet (1) · Juntendo University (1) · National Cerebral and Cardiovascular Center, Japan (1) · National Taiwan University Hospital (1)
China (4) · Canada (3) · Japan (2) · South Korea (1) · Taiwan (1)
Robert Bissonnette, MD (2) · Anthony Fung, MBBS, FRCPC (1) · Chen Yundai (1) · Jean-Claude Tardif, MD (1) · Jean-Claude Tardif, MD, FRCPC (1) · Tzung-Dau Wang, MD, PhD (1) · Yu Kataoka, MD (1)
PMID 21471671, PMID 23204039, PMID 23214115, PMID 26739013, PMID 28286061, PMID 31737515